|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
"Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.
|
29735609 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
<b>Aims:</b> Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) are members of the glycosylphosphatidylinositol (GPI)-linked immunoglobulin (Ig) superfamily and take part in regulation of cell adhesion, tumor suppression and angiogenesis.
|
31171910 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
50nM - 100nM) of ST were used, the percentage of CEA positive cells declined compared to that detected in 25nM-treated tumor.
|
10789557 |
2000 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor resection increased significantly the positive rates of CEA-mRNA in the blood stream of three kinds of vessel.
|
10414697 |
1999 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor cell lines established from CEA424/Tag-CEA mice express the well defined tumor antigen CEA under the control of its natural regulatory elements.
|
16536871 |
2006 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor weights are diminished after intratumoral injections of MV-producing carcinoembryonic antigen in one of two cell lines and result in detectable viral transgene in serum of mice.
|
25157763 |
2014 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor carcinoembryonic antigen expression was significantly reduced in both treatment groups (p < 0.05).
|
26995061 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor markers (CEA, CA(cancer antigens) 72.4, CA 19-9) , amylase, lipase and cytological assesment were compared between 3 different groups.
|
28072692 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor markers were measured with an electrochemiluminescent assay and the reference value was 5ng/ml for CEA and for Ca19-9, 37u/ml.
|
28315907 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor biomarkers carcinoembryonic antigen (CEA) and TAG-72 were measured in serum; there was a precipitous decline of TAG-72, but not CEA, in some patients due to induction of an interfering antibody to the TAG-72 binding domain of humanized CC49, reflecting an anti-CAR immune response.
|
28344808 |
2017 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor markers were negative for carbohydrate antigen 19-9 and 72-4 (CA 19-9, CA 72-4) and carcinoembryonic antigen (CEA).
|
30541485 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor markers such as carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) are widely used for monitoring breast cancer.
|
31312932 |
2019 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor-specific gene expression can be achieved by coupling the promoter for the carcinoembryonic antigen (CEA) to a gene such as herpes simplex virus thymidine kinase (HSV-tk), which phosphorylates ganciclovir to a potent DNA synthesis inhibitor.
|
8047987 |
1994 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor markers such as CA19-9 and CEA are used for diagnosis and for following the postoperative course of cancer patients.
|
8862512 |
1996 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectors.
|
8898638 |
1996 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CEA is an important tumor marker for colorectal and some other carcinomas.
|
10202129 |
1999 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Carcinoembryonic antigen (CEA) is highly expressed by most tumours of gastrointestinal origin, but its use as a target for tumour therapy is complicated by the high levels of soluble CEA that are found circulating in the blood of cancer patients.
|
10203059 |
1999 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
CEA mRNA positivity was detected most frequently after tumor resection and correlated with nodal status and stage grouping.
|
12605177 |
2003 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CEA transgenic mice were transplanted with CEA-expressing tumors.
|
12738742 |
2003 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CEA is used as a valuable serum tumor marker for monitoring response to therapy in patients with various solid tumors.
|
12801635 |
2003 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
CEA mRNA expression was also closely correlated with E-cadherin mRNA expression in the primary tumor (P<0.001) and in the adjacent hepatocytes of the liver metastasis (P=0.018).
|
14592671 |
2003 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway.
|
16035616 |
2004 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CEA.tg mice were protected from tumor growth on challenge with MC38-CEA tumor cells only when immunized with repeated injections of plasmid pV1J/CEA-DOM followed by Ad/CEA-DOM.
|
16409127 |
2006 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Carcinoembryonic antigen (CEA) has been shown to be involved in a variety of neoplasia process, such as tumor cell adhesion, metastasis, blocking of cellular immune mechanisms, and anti-apoptosis function.
|
16945335 |
2006 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
CEA mRNA positivity significantly correlated with tumor depth, lymph node metastasis, stage, and venous invasion.
|
17062668 |
2006 |